a viable strategy for long-term growth. Even LOE. To sustain momentum, companies must and life cycle management. To fully capture this value, companies must excel in launch the portfolio, maintain commercial relevance expand geographic reach. Sustained growth density, these multi-indication assets are projected revenue growth. Notably, just 13 such therapies, each spanning four or more indications, are set to deliver nearly 20% of topline expansion through 2030. Their
原图定位
